Amit Karpe, 3M explains how it is challenging the traditional clarification process. Using its expertise and technology platforms, the company is approaching it with a different perspective
Monoclonal antibody manufacturing is a complex process which includes numerous stages. The process consists of cell culture, cell harvest, protein-A capture, virus inactivation, product concentration, sterile filtration and filling. Service providers push for innovation in the processes downstream of protein-A column. The same cannot be said for upstream process.